Skip to main navigation
Tactile Medical
  • About Lymphedema
    • Overview
    • Signs & Symptoms
    • Treatment
    • Management
  • Products
    • Overview
    • FLEXITOUCH® system
    • Entre™ System
    • Actitouch® System
    • Clinical Evidence
  • Patients
    • Overview
    • Signs & Symptoms
    • Patient Testimonials
    • Lymphedema Partners
  • Healthcare Professionals
    • Overview
    • Health Plan Coverage
    • Veterans Affairs
    • Clinical Evidence
    • Professional Resources
    • Thought Leadership
  • Investors
    • News
    • Events & Webcasts
    • Stock Information
    • Annual Reports & SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Contacts
  • About Us
    • Who We Are
    • Leadership
    • News
    • Careers
Patient Portal
Select Page

News

News

20192018201720162015201420132012
December 7, 2017
Tactile Medical to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
MINNEAPOLIS , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim
Read More »
December 7, 2017
Tactile Medical Announces New Clinical Publication Assessing the Use of Flexitouch for the Treatment of Head & Neck Lymphedema
MINNEAPOLIS , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the publication of a functional use study in the
Read More »
November 16, 2017
Tactile Medical to Participate in the 29th Annual Piper Jaffray Healthcare Conference
MINNEAPOLIS , Nov. 16, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the 29th Annual
Read More »
November 7, 2017
Tactile Systems Technology, Inc. Reports Third Quarter 2017 Financial Results; Updates 2017 Outlook
Q3 Revenue Increase of 25% Year-over-Year; Revenue Up 33% Year-to-Date MINNEAPOLIS , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at
Read More »
October 11, 2017
Tactile Medical to Release Third Quarter 2017 Financial Results on November 7, 2017
MINNEAPOLIS , Oct. 11, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that third quarter 2017 financial results will be
Read More »
September 20, 2017
Tactile Medical Announces Appointment of Raymond Huggenberger to Board of Directors
MINNEAPOLIS , Sept. 20, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Raymond O.
Read More »
September 13, 2017
Tactile Medical Announces Pricing of Secondary Offering of Common Stock
MINNEAPOLIS , Sept. 13, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology , Inc. (“ Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the pricing of a previously
Read More »
September 12, 2017
Tactile Medical Announces Secondary Offering of Common Stock
MINNEAPOLIS , Sept. 12, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology , Inc. (“ Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that certain of its stockholders
Read More »
August 7, 2017
Tactile Systems Technology, Inc. Reports Second Quarter 2017 Financial Results; Updates 2017 Outlook
Q2 Revenue Increase of 33% Year-over-Year; Revenue Up 38% Year-to-Date MINNEAPOLIS , Aug. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at
Read More »
August 1, 2017
Tactile Medical Announces Appointment of Cheryl Pegus to Board of Directors
MINNEAPOLIS , Aug. 01, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Cheryl Pegus , MD, MPH, to the
Read More »

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »
Displaying 1 - 10 of 23
  • RSS Feeds
  • Email Alerts
  • Investor Contacts
  • Print Page
  • E-mail Page
Logo


Tactile Systems Technology, Inc. BBB Business Review
  • About Lymphedema
  • Products
  • Patients
  • Healthcare Professionals
  • Investors
  • About Us
  • Careers
  • Pay My Bill
  • Patient Contact Us
  • Clinician Contact Us
  • Forms
  • Media Resources
  • Privacy Statement
  • Terms & Conditions
  • Warranty & Return Policies
1331 Tyler Street NE, Suite 200
Minneapolis, MN 55413 USA

Phone: 612.355.5100
Toll-free: 866.435.3948
Fax: 866.435.3949
facebook linkedin twitter youTube
Flexitouch, Actitouch, Entre and HEALING RIGHT AT HOME are all trademarks or registered trademarks of Tactile Medical.
D/N500187-000-00 Rev. J 11/2017